AMFPF
Price
$16.11
Change
-$2.22 (-12.11%)
Updated
Sep 25 closing price
Capitalization
3.57B
COSM
Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Sep 26 closing price
Capitalization
33.49M
Interact to see
Advertisement

AMFPF vs COSM

Header iconAMFPF vs COSM Comparison
Open Charts AMFPF vs COSMBanner chart's image
Amplifon S.p.A
Price$16.11
Change-$2.22 (-12.11%)
Volume$397
Capitalization3.57B
Cosmos Health
Price$1.08
Change-$0.01 (-0.92%)
Volume$334.33K
Capitalization33.49M
AMFPF vs COSM Comparison Chart in %
Loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. COSM commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and COSM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (AMFPF: $16.11 vs. COSM: $1.08)
Brand notoriety: AMFPF and COSM are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 3% vs. COSM: 35%
Market capitalization -- AMFPF: $3.57B vs. COSM: $33.49M
AMFPF [@Medical Distributors] is valued at $3.57B. COSM’s [@Medical Distributors] market capitalization is $33.49M. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 1 FA rating(s) are green whileCOSM’s FA Score has 1 green FA rating(s).

  • AMFPF’s FA Score: 1 green, 4 red.
  • COSM’s FA Score: 1 green, 4 red.
According to our system of comparison, COSM is a better buy in the long-term than AMFPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 4 TA indicator(s) are bullish while COSM’s TA Score has 5 bullish TA indicator(s).

  • AMFPF’s TA Score: 4 bullish, 2 bearish.
  • COSM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMFPF and COSM are a good buy in the short-term.

Price Growth

AMFPF (@Medical Distributors) experienced а -12.11% price change this week, while COSM (@Medical Distributors) price change was +13.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($3.57B) has a higher market cap than COSM($33.5M). COSM YTD gains are higher at: 61.435 vs. AMFPF (-38.044). AMFPF has higher annual earnings (EBITDA): 549M vs. COSM (-12.84M). AMFPF has more cash in the bank: 243M vs. COSM (686K). COSM has less debt than AMFPF: COSM (15.6M) vs AMFPF (1.83B). AMFPF has higher revenues than COSM: AMFPF (2.41B) vs COSM (55.1M).
AMFPFCOSMAMFPF / COSM
Capitalization3.57B33.5M10,657%
EBITDA549M-12.84M-4,275%
Gain YTD-38.04461.435-62%
P/E Ratio24.60N/A-
Revenue2.41B55.1M4,377%
Total Cash243M686K35,423%
Total Debt1.83B15.6M11,744%
FUNDAMENTALS RATINGS
AMFPF vs COSM: Fundamental Ratings
AMFPF
COSM
OUTLOOK RATING
1..100
5045
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6598
PRICE GROWTH RATING
1..100
9035
P/E GROWTH RATING
1..100
847
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMFPF's Valuation (26) in the null industry is somewhat better than the same rating for COSM (78). This means that AMFPF’s stock grew somewhat faster than COSM’s over the last 12 months.

AMFPF's Profit vs Risk Rating (100) in the null industry is in the same range as COSM (100). This means that AMFPF’s stock grew similarly to COSM’s over the last 12 months.

AMFPF's SMR Rating (65) in the null industry is somewhat better than the same rating for COSM (98). This means that AMFPF’s stock grew somewhat faster than COSM’s over the last 12 months.

COSM's Price Growth Rating (35) in the null industry is somewhat better than the same rating for AMFPF (90). This means that COSM’s stock grew somewhat faster than AMFPF’s over the last 12 months.

COSM's P/E Growth Rating (7) in the null industry is significantly better than the same rating for AMFPF (84). This means that COSM’s stock grew significantly faster than AMFPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFCOSM
RSI
ODDS (%)
Bullish Trend 3 days ago
22%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
26%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
19%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
28%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
22%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
22%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
5%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIVL23.240.18
+0.77%
Madison Dividend Value ETF
IGRO78.810.43
+0.55%
iShares International Dividend Gr ETF
BILZ101.170.03
+0.03%
PIMCO Ultra Short Government Active ETF
CZAR32.42N/A
N/A
Themes Natural Monopoly ETF
PQJL28.14N/A
N/A
PGIM NASDAQ-100 BUFFER 12 ETF - JULY

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and COR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and COR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
COR - AMFPF
24%
Poorly correlated
+2.74%
ZYXI - AMFPF
7%
Poorly correlated
-1.36%
NSVGF - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
ARRJF - AMFPF
-0%
Poorly correlated
N/A
More

COSM and

Correlation & Price change

A.I.dvisor tells us that COSM and EDAP have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COSM and EDAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COSM
1D Price
Change %
COSM100%
-0.92%
EDAP - COSM
16%
Poorly correlated
-3.97%
MEPDF - COSM
12%
Poorly correlated
N/A
OMI - COSM
10%
Poorly correlated
-1.45%
AMFPF - COSM
4%
Poorly correlated
N/A
HSIC - COSM
4%
Poorly correlated
+0.64%
More